[Impairment of myocardial perfusion reserve in microvascular angina (syndrome X): assessment by 99mTc-MIBI-SPECT]

Nuklearmedizin. 1996 Dec;35(6):193-7.
[Article in German]

Abstract

Aim: In 22 patients with typical chest pain and normal coronary arteries (microvascular angina, syndrome X) 99mTc-MIBI-SPECT was examined in regard to assess impairment of myocardial perfusion reserve.

Method: The study was performed with 99mTc-MIBI-SPECT at rest and under vasodilation with dipyridamole. The findings were compared with a normal database. A normal perfusion reserve was said to be an increase > 20% of the 99mTc-MIBI-activity.

Results: In 2/22 (9%) of the patients the perfusion reserve lay > 20% i.e. 37%. In 91% of the patients a diminution or even decrease of the perfusion was to be seen. From these 9/22 (41%) of the patients showed a diminution of the 99mTc-MIBI-uptake by 6%. 1/22 patients had a decrease of the perfusion under vasodilation with dipyridamole i.e. a lower activity of 99mTc-MIBI by 13%

Conclusion: Vasodilation 99mTc-MIBI-SPECT offers good imaging quality and enables semi-quantitative assessment of myocardial perfusion reserve in patients with microvascular angina.

MeSH terms

  • Blood Pressure
  • Chest Pain
  • Dipyridamole
  • Female
  • Heart / diagnostic imaging*
  • Heart / drug effects
  • Heart / physiopathology
  • Heart Rate
  • Humans
  • Male
  • Microvascular Angina / diagnostic imaging*
  • Middle Aged
  • Technetium Tc 99m Sestamibi*
  • Tomography, Emission-Computed, Single-Photon*

Substances

  • Dipyridamole
  • Technetium Tc 99m Sestamibi